NIH-funded research R01 grant

Optical control of the actin cytoskeleton for cellular function

Official title: Optical Control of the Actin Cytoskeleton

Funded at University of Pennsylvania · NIH-11616949 · Data updated 2026-11-12

A scientist is developing light-activated molecules to precisely control how actin filaments behave in human and animal cells.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 1, 2018
Project endAugust 31, 2027
Funding year2026
Award (this year)$23,408
NIH project number3R01GM126228-08S1
Project IDNIH-11616949 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals whose condition involves abnormal cell movement or actin-related processes and who may participate in future translational research or related clinical studies.

Less likely to help

Patients not involved in actin-related disease pathways or those not eligible for future translational studies may not benefit directly.

What this research studies

This project explores photoswitchable compounds that can turn actin dynamics on and off with light, affecting G-actin and F-actin, as well as key actin-regulating proteins. The work covers several cellular systems and aims to create probes that researchers can use to study cell movement and structure. If successful, these tools could lead to new ways to influence cell behavior in diseases where movement and organization of cells matter.

Why it matters

Potential benefit: If successful, patients could benefit from future therapies that target cell movement and organization with precise, light-controlled drugs.

How similar studies have gone: Similar approaches using photoswitchable molecules have shown precise control of actin dynamics in cells, with promising use as research tools and potential therapies.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Trauner, Dirk Hartwig — University of Pennsylvania
  • Study coordinator: Trauner, Dirk Hartwig

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.